The largest US physician organization seeks greater accountability about insurers use of AI-enabled tools as well as limits on physician liability in connection with these products.
With the help of AI, arterial inflammation measured with coronary computed tomography angiography can predict fatal and nonfatal events in patients with nonobstructive CAD.
A once-daily pill of modified vitamin A slowed the rate of retinal degeneration in patients with Stargardt disease, a rare genetic eye disease that can cause vision loss.
After a positive FDA panel review in August, the FDA has approved the Paradise Ultrasound Renal Denervation system for the treatment of hypertension, manufacturer Recor and parent company Otsuka announced.